Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions

Neoplasia

Volumn 12, Issue 10, 2010, Pages 818-825

  Røe, Kathrine ^a,b   Seierstad, Therese ^a,c   Kristian, Alexandr ^a   Mikalsen, Lars Tore Gyland ^b   Mælandsmo, Gunhild Mari ^a,d   van der Kogel, Albert J ^e   Ree, Anne Hansen ^a,b   Olsen, Dag Rune ^f  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER RADIOTHERAPY; CASTRATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; INTERVENTIONAL RADIOLOGY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION RESPONSE; TUMOR VASCULARIZATION; TUMOR VOLUME; TUMOR XENOGRAFT; VOXEL BASED MORPHOMETRY;

EID: 77957771802     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.10484     Document Type: Article

References (20)

1. Nicholson B and Theodorescu D (2004). Angiogenesis and prostate cancer tumor growth. J Cell Biochem 91(1), 125-150.
2. Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, et al. (2009). Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 373(9660), 301-308.
3. Westin P, Stattin P, Damber JE, and Bergh A (1995). Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Am J Pathol 146(6), 1368-1375.
4. Pollack A, Joon DL, Wu CS, Sikes C, Hasegawa M, Terry NH, White RA, Zagars GK, and Meistrich ML (1997).Quiescence in R3327-Grat prostate tumors after androgen ablation. Cancer Res 57(12), 2493-2500.
5. Jain RK, Safabakhsh N, Sckell A, Chen Y, Jiang P, Benjamin L, Yuan F, and Keshet E (1998). Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc Natl Acad Sci USA 95(18), 10820-10825.
6. Hillman GG, Singh-Gupta V, Zhang H, Al-Bashir AK, Katkuri Y, Li M, Yunker CK, Patel AD, Abrams J, and Haacke EM (2009). Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors. Neoplasia 11(9), 910-920.
7. Cho HJ, Ackerstaff E, Carlin S, Lupu ME, Wang Y, Rizwan A, O'Donoghue J, Ling CC, Humm JL, Zanzonico PB, et al. (2009). Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia. Neoplasia 11(3), 247-259.
8. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, et al. (1999). Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10(3), 223-232.
9. Lee AK (2006). Radiation therapy combined with hormone therapy for prostate cancer. Semin Radiat Oncol 16(1), 20-28.
10. Wainstein MA, He F, Robinson D, Kung HJ, Schwartz S, Giaconia JM, Edgehouse NL, Pretlow TP, Bodner DR, and Kursh ED (1994).CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res 54(23), 6049-6052.
11. Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, Schwartz S, Kung HJ, de Vere White RW, Gumerlock PH, Resnick MI, et al. (1996). CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res 56(13), 3042-3046.
12. Seierstad T, Roe K, and Hovik B (2007). Construction of a modified capacitive overlap MR coil for imaging of small animals and objects in a clinical wholebody scanner. Phys Med Biol 52(22), N513-N522.
13. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, and Kramer J (1994). Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 31(5), 567-571.
14. Schuuring J, Bussink J, Bernsen HJ, Peeters W, and van der Kogel AJ (2006). Effect of carbogen breathing on the radiation response of a human glioblastoma xenograft: analysis of hypoxia and vascular parameters of regrowing tumors. Strahlenther Onkol 182(7), 408-414.
15. Marignol L, Coffey M, Lawler M, and Hollywood D (2008).Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treat Rev 34(4), 313-327.
16. Hockel M and Vaupel P (2001). Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4), 266-276.
17. Bradley DP, Tessier JJ, Ashton SE, Waterton JC, Wilson Z, Worthington PL, and Ryan AJ (2007). Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic rats. Neoplasia 9(5), 382-391.
18. Galbraith SM, Maxwell RJ, Lodge MA, Tozer GM, Wilson J, Taylor NJ, Stirling JJ, Sena L, Padhani AR, and Rustin GJ (2003). Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol 21(15), 2831-2842.
19. Dyke JP, Zakian KL, Spees WM, Matei C, Chen Y, Mao X, Shungu DC, and Koutcher JA (2003). Metabolic response of the CWR22 prostate tumor xenograft after 20 Gy of radiation studied by 1H spectroscopic imaging. Clin Cancer Res 9(12), 4529-4536.
20. Pretlow TG, Wolman SR, Micale MA, Pelley RJ, Kursh ED, Resnick MI, Bodner DR, Jacobberger JW, Delmoro CM, and Giaconia JM (1993). Xenografts of primary human prostatic carcinoma. J Natl Cancer Inst 85(5), 394-398.